Bausch + Lomb Corporation (BLCO)

USD 11.9

(0.42%)

Total Assets Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual total assets in 2023 was 13.44 Billion USD , up 20.62% from previous year.
  • Bausch + Lomb Corporation's latest quarterly total assets in 2024 Q3 was 13.51 Billion USD , up 2.0% from previous quarter.
  • Bausch + Lomb Corporation reported annual total assets of 11.14 Billion USD in 2022, up 2.97% from previous year.
  • Bausch + Lomb Corporation reported annual total assets of 10.82 Billion USD in 2021, down -3.93% from previous year.
  • Bausch + Lomb Corporation reported quarterly total assets of 13.25 Billion USD for 2024 Q2, down -0.32% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly total assets of 13.29 Billion USD for 2024 Q1, down -1.11% from previous quarter.

Annual Total Assets Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Total Assets of Bausch + Lomb Corporation (2023 - 2019)

Year Total Assets Total Assets Growth
2023 13.44 Billion USD 20.62%
2022 11.14 Billion USD 2.97%
2021 10.82 Billion USD -3.93%
2020 11.26 Billion USD -1.76%
2019 11.46 Billion USD 0.0%

Peer Total Assets Comparison of Bausch + Lomb Corporation

Name Total Assets Total Assets Difference
Alcon Inc. 29.6 Billion USD 54.594%
AptarGroup, Inc. 4.45 Billion USD -201.939%
Baxter International Inc. 28.27 Billion USD 52.461%
Becton, Dickinson and Company 52.78 Billion USD 74.532%
Haemonetics Corporation 2.19 Billion USD -512.227%
Envista Holdings Corp 6.6 Billion USD -103.509%
ResMed Inc. 6.87 Billion USD -95.594%
Teleflex Incorporated 7.53 Billion USD -78.452%
Warby Parker Inc. 580.31 Million USD -2216.34%
West Pharmaceutical Services, Inc. 3.82 Billion USD -251.012%